Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 3Phase 4 1Phase 3 1

Status

Recruiting 2Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Myeloid 3

Conditions

Carcinoma, Non-Small-Cell Lung 61Neoplasms 52Neoplasm Metastasis 48Leukemia, Myeloid, Acute 47Colorectal Neoplasms 47Breast Neoplasms 44Prostatic Neoplasms 37Multiple Myeloma 33Ovarian Neoplasms 31Recurrence 27Melanoma 26Pancreatic Neoplasms 25Lymphoma, Non-Hodgkin 25Squamous Cell Carcinoma of Head and Neck 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Myelodysplastic Syndromes 22Triple Negative Breast Neoplasms 21Endometrial Neoplasms 21Lung Neoplasms 19Carcinoma, Renal Cell 19Stomach Neoplasms 18Small Cell Lung Carcinoma 18Sarcoma 18Advanced Solid Tumors 18Brain Neoplasms 17Glioblastoma 16Carcinoma, Hepatocellular 16Esophageal Neoplasms 13Solid Tumors 12Lymphoma, B-Cell 12

Interventions

umbralisib 1ruxolitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Polycythemia Vera × 30 days × Clear all
NCT07441694 2026-05-29

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Incyte Corporation

Phase 1 Recruiting
218 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT07469891 2026-05-29

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

Prelude Therapeutics

Phase 1 Recruiting
100 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Primary Myelofibrosis

NCT02493530 2026-05-19

TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea

Vanderbilt-Ingram Cancer Center

Phase 1 Completed
60 enrolled
Myeloid

Polycythemia Vera, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡